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ABSTRACT 
 
While canonical NF-B signaling is crucial to generate a normal mature B cell 
compartment, its role in the persistence of resting mature B cells is controversial. To 
resolve this conflict, we ablated NEMO and IKK2, two essential mediators of the 
canonical pathway, either early on in B cell development or specifically in mature B 
cells. Early ablation severely inhibited the generation of all mature B cell subsets, but 
follicular B cell numbers could be largely rescued by ectopic expression of Bcl2, despite 
a persisting block at the transitional stage. Marginal zone B and B1 cells were not 
rescued, indicating a possible role of canonical NF-B signals beyond the control of cell 
survival in these subsets. When canonical NF-B signaling was ablated specifically in 
mature B cells, the differentiation and/or persistence of marginal zone B cells was still 
abrogated, but follicular B cell numbers were only mildly affected. However, the mutant 
cells exhibited increased turnover as well as functional deficiencies upon activation, 
suggesting that canonical NF-B signals contribute to their long-term persistence and 
functional fitness. 
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SIGNIFICANCE 
 
Mature B cells are long-lived cells responsible for the antibody production in the immune 
system. Canonical NF-B signaling, one of the two discrete pathways activating 
transcription factors of the NF-B family, participates in the generation of a normal 
mature B cell compartment. However, the role of these signals specifically in mature B 
cells is still imperfectly defined. Notably, their role in the persistence of follicular B cells, 
the main mature B cell subset, is controversial. Here, we show that canonical NF-B 
signaling does not contribute to immediate (short-term) survival of follicular B cells, 
contrasting with the crucial tonic B cell antigen receptor survival signals, but is required 
for their long-term persistence as well as functional fitness. 
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INTRODUCTION 
 
Mature B cells comprise three major subsets: follicular and marginal zone (MZ) B and 
B1 cells (1). Two receptors, the B cell antigen receptor (BCR) and B cell-activation 
factor of the tumor necrosis factor family (BAFF) receptor (BAFFR) have been shown to 
critically control the generation and/or persistence of mature B cells (2-5). 
Numerous stimuli activate the NF-B signaling pathways in mature B cells. In 
mammals, the NF-B family of transcription factors comprises 5 members (RelA, RelB, 
c-Rel, NF-B1 and NF-B2) whose activation is initiated by two major signaling 
pathways (5). The canonical pathway depends on the IKK complex, consisting of the 
structural protein NEMO and the IB kinases IKK1 and IKK2. This complex triggers the 
degradation of a specific set of inhibitors of NF-B and, the induction of dimers 
containing RelA and/or c-Rel. The canonical pathway regulates NF-B activation 
downstream of the BCR (5). The stimulation of the alternative pathway, mediated by NF-
B inducing kinase and IKK1, leads to the partial proteolysis of the inhibitory precursor 
NF-B2 and the activation of dimers containing RelB and/or the processed form of NF-
B2 through another set of receptors including BAFFR (4). 
There is abundant evidence for a critical role of the canonical pathway in the 
generation and/or maintenance of mature B cells. The ablation of NEMO or IKK2 in the 
B cell lineage, as well as conditional replacement of the latter by a kinase-dead IKK2, 
impaired the generation of the three mature B subsets and transitional 2 (T2) cells, a 
developmental stage preceding the mature stage (6-9). In the case of the kinase-dead 
IKK2 some mutant cells made it into the mature compartment, but were completely 
outcompeted by wild type cells over a period of four weeks, upon blockade of B cell 
generation in the bone marrow (6). Mechanistically, tonic BCR signaling could increase 
the production of NF-B2 via canonical NF-B activation in T2 and follicular B cells, 
sensitizing B cells to the pro-survival effect of BAFFR (10). 
However, other work suggested that canonical signals downstream of the BCR 
may not be critical for the maintenance of mature follicular B cells. Ectopic expression of 
a constitutively active form of IKK2 only slightly rescued the acute loss of B cells upon 
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ablation of the BCR in these cells, whereas a full rescue was obtained through signals 
along the PI3K – FOXO1 axis (11). In addition, a study of the role of B cells in a prostate 
cancer model suggested that the absence of canonical signaling may not result in the 
rapid disappearance of mature B cells (12). 
In the present work, using conditional ablation of NEMO and IKK2 either early during B 
cell development or specifically in mature B cells as well as ectopic expression of Bcl2, 
we show that canonical NF-B signaling contributes to the functional integrity of 
follicular B cells, and supports their long-term persistence through its pro-survival 
activity. However, absence of canonical NF-B signaling in these cells only mildly 
affects their numbers in steady state, in contrast to its severe impact on transitional B cell 
numbers. 
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RESULTS 
 
Ectopic expression of Bcl2 allows accumulation of follicular B cells upon NEMO 
deletion early in development 
 
Consistent with previous work (6, 8, 9), the generation of mature B cells was impaired 
upon ablation of NEMO in the B cell lineage using Mb1-cre (Fig. 1 A and B; Figs. S1A 
and S2A) (13). Within the mature compartment, MZ B and B1 cells were more affected 
than follicular B cells. As over-expression of Bcl2 in c-Rel—/—RelA—/— hematopoietic 
cells has been shown to rescue the generation of mature B cells and promote their 
survival in vitro (14), we assessed whether ectopic expression of Bcl2 leads to the 
accumulation of mature B cells in the absence of NEMO. Indeed, the generation of 
follicular B was largely rescued in Nemofl Mb1-cre+ Bcl2Tg mice (Fig. 1A; Fig. S1B). In 
contrast, mutant MZ B cellularity was lower (2 – 5.5 fold) compared to controls and was 
similar to the MZ B cell numbers observed in Nemofl Mb1-cre+ mice (Fig. 1A; Fig. S1B). 
However, the difference between Mb1-cre+ Bcl2Tg and Nemofl Mb1-cre+ Bcl2Tg mice 
did not reach statistical significance. Surprisingly, MZ B cellularity was also reduced in 
Mb1-cre+ Bcl2Tg compared to Mb1-cre— Bcl2Tg control mice. In addition, the ectopic 
expression of Bcl2 in B cells did not rescue NEMO-deficient B1 cells in the peritoneal 
cavity (Fig. 1B; Fig. S2B). 
The absence of canonical NF-B signaling in B cells has previously been shown 
to affect splenic B cell development also at the T1 to T2 transition (8, 9). We thus 
investigated whether the accumulation of mutant follicular B cells could be due to the 
rescue of T2 cell generation in Nemofl Mb1-cre+ Bcl2Tg mice. T2 cell numbers 
demonstrated a positive correlation with T1 cellularity (Fig. 1C; Fig. S3), in agreement 
with T2 cells arising from the T1 subset (15). Notably, the production of NEMO-
deficient T2 cells was clearly reduced compared to controls, independently of the over-
expression of Bcl2 (Fig. 1C). CD23, used to discriminate T1 and T2 cells (15), has been 
reported to be an NF-B target gene (16). We therefore confirmed the identity of the 
mutant transitional populations using an independent marker, CD93, which is expressed 
at lower levels in T2 cells (Fig. 1D; Fig. S4) (3, 9). Comparable distributions of CD93lo 
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cells were seen in the transitional subsets of Nemofl Mb1-cre+ Bcl2Tg and control mice, 
supporting that genuine T1 and T2 cells were detected in the mutant mice. 
Thus, ectopic expression of Bcl2 permitted the accumulation of NEMO-deficient 
follicular B cells close to normal cellularity despite a persisting developmental block at 
the transitional stage. In contrast, the generation of MZ B and B1 cells was not rescued, 
possibly due to a role for canonical NF-B signaling beyond cell survival (17), consistent 
with the inability of a Bcl2 transgene regulated by vav gene regulatory elements to 
promote the development of MZ B cells in NF-B1-deficient mice (18). 
 Peripheral B cells from Ikk2fl CD19-cre+ mice showed altered in vitro and in vivo 
responses to stimulation (7), but these results could have been partly due to the reduced 
numbers of mature B cells in these mice. The large numbers of follicular B cells in 
Nemofl Mb1-cre+ Bcl2Tg allowed us to examine their responses to various kinds of 
stimulation. The NEMO-deficient Bcl2Tg B cells exhibited an impaired proliferative 
response to various mitogenic stimuli in vitro compared to control Bcl2Tg B cells (Fig. 
2A). Consistent with defective B cell functions, IgM and IgG serum antibody levels were 
strongly reduced or undetectable (Fig. 2B). In the T cell dependent response to 
immunization with (4-hydroxy-3-nitrophenyl)acetyl (NP)–chicken -globulin, the 
frequency of germinal center cells was strongly reduced and the production of anti-NP 
IgG1 antibodies abolished (Fig. 2 C and D). These data show that canonical NF-B 
signals are essential for the functional activity of follicular B cells, and complement a 
large body of evidence for the multi-faceted role of this pathway in the control of 
humoral immunity (5, 17, 19). 
 
Long-term persistence of follicular B cells requires canonical NF-B signaling 
 
To directly evaluate the contribution of canonical signaling to the maintenance of mature 
B cells, we ablated NEMO using CD21-cre (3). We excluded B1 cells from the analysis 
since, in our hands, CD21-cre proved to be poorly expressed in the prototypical CD5+ 
B1a subset (Fig. S5). A large follicular B cell population was detected in the spleens of 
Nemofl CD21-cre+ mice, while MZ B cells were essentially lost (Fig. 3 A and B). Similar 
results were obtained upon IKK2 ablation through CD21-cre (Fig. 3 C and D). These data 
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contrast with the small mature B cell compartment detected in the absence of NEMO or 
IKK2 using the CD19-cre or Mb1-cre alleles (6-9). Nemofl and Ikk2fl loxP-flanked exons 
are efficiently eliminated upon Cre-mediated recombination in B cells (6, 8), which we 
verified in the case of follicular B cells from Ikk2fl CD21-cre+ mice (Fig. 4). The mild 
reduction of follicular B cell numbers in Ikk2fl CD21-cre+ mice was not due to the 
accumulation of cells that had escaped IKK2 deletion. Indeed, the majority of these cells 
expressed a Cre-inducible truncated human CD2 reporter gene (Fig. 4 A and B), and the 
reporter positive cells demonstrated dramatically reduced IKK2 protein levels compared 
to controls (Fig. 4C). 
Residual splenic mature B cells expressing a kinase-dead IKK2 have been shown 
to display an increased turnover compared to controls (6). Thus, we assessed whether 
follicular B cell persistence was altered in Ikk2fl CD21-cre+ mice by measuring 5-bromo-
2'-deoxyuridine (BrdU) incorporation into their DNA after two weeks of labeling. 
Labeling efficiency was similar between the various mice as indicated by comparable 
proportions of BrdU+ transitional B cells (Fig. 4D). In agreement with previous work (3, 
20), follicular B cells from wild-type (CD21-cre—) and Ikk2fl/+ CD21-cre+ controls 
showed low proportions (12 – 13%) of BrdU+ cells. In contrast, 40% of IKK2-deficient 
follicular B cells had incorporated BrdU (Fig. 4D), suggesting increased turnover. 
Overall, the present results suggest that the main function of canonical NF-B 
signaling in follicular B cell homeostasis is indeed the control of cell survival, as 
demonstrated by the ability of a Bcl2 transgene to rescue a substantial compartment of 
these cells even under conditions where the ablation of canonical signaling in the B cell 
lineage leads to a severe developmental block at the transitional B cell stage (8, 9). This 
is in line with earlier work showing the accumulation of mature B cells in mice 
reconstituted with RelA and c-Rel double deficient Bcl2 transgenic fetal liver cells (14). 
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DISCUSSION 
 
While ablation of components of the BCR in mature B cells led to a steady state in which 
BCR-deficient cells were a minority of the mature B cell population because of their 
rapid elimination (2, 3, 11), NEMO or IKK2 ablation by CD21-cre resulted in an only 
moderate reduction of follicular B cell numbers. This indicates that follicular B cells do 
not require continuous canonical NF-B signaling for their persistence, and contrasts 
with the rapid loss of B cells upon BCR deletion (2, 3). Quite fittingly the latter process 
can be rescued by constitutive PI3K activation, but not canonical NF-B activity (11). 
However, the homeostasis of follicular B cells unable to signal through the canonical NF-
B pathway is clearly different from that of their wild type counterparts. While the latter 
are long-lived cells with average life spans of months (21), the mutant follicular B cells 
appear to have a limited life span, probably in the order of a few weeks as indicated by 
the BrdU labeling data. These results complement our previous demonstration of the 
failure of such cells to compete with wild type cells in vivo (6). Together with the 
accumulation of NEMO-deficient follicular B cells upon ectopic expression of Bcl2, 
these data raise the possibility that canonical NF-B signals may determine the fitness of 
mature follicular B cells in their competition for survival niches in the peripheral immune 
system (22). 
The ablation of NEMO or IKK2 early during B cell development results in 
strongly reduced numbers of follicular B cells (6-9), in stark contrast to the effects of the 
deletion of these two molecules specifically in mature B cells. This difference likely 
reflects the critical role of canonical NF-B signaling in transitional B cells (6, 8, 9). In 
combination with the limited life span of follicular B cells, the shortage of newly 
generated mature B cells is expected to lead to the suboptimal filling of the follicular B 
compartment, in the absence of canonical NF-B signaling. 
Compared to follicular B cells, MZ B and B1 cells demonstrate a stronger 
dependency on canonical NF-B signals for their development and/or persistence. Thus, 
MZ B cell numbers were strongly reduced in Nemofl and Ikk2fl CD21-cre+ mice, and the 
ectopic expression of Bcl2 failed to rescue the generation and/or maintenance of NEMO-
deficient MZ B and B1 cells. These results are suggestive of a role beyond the control of 
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survival for canonical NF-B signaling in MZ B and B1 cells. It is noteworthy in this 
context that Cyclin D2, a regulator of the cell cycle and a target of NF-B, contributes to 
the development of B1 cells (23). 
While an important signaling pathway activated in B cells upon engagement of 
BAFFR is the alternative NF-B signaling pathway (4), there is also evidence for a cross-
talk between the alternative and canonical pathways, both in the sense of BAFFR 
signaling resulting in canonical NF-B activity (8, 24), and of canonical signals 
upregulating the expression of components of the alternative pathway (8, 10, 17, 19). 
Thus, BAFFR might be involved in the activation of survival signals in mature B cells 
through both the canonical and the alternative NF-B signaling pathway, and/or 
canonical signals could contribute to an enhanced sensitivity of the corresponding cells to 
survival signals downstream of BAFFR. In this scenario, the occasional engagement of 
the BCR on resting mature B cells by antigens in the environment, with a resulting 
activation of the canonical NF-B pathway, might enhance the competitive fitness of the 
cells in their ability to access survival niches (22). The activation of canonical NF-B 
signaling downstream of the BCR and/or BAFFR could be mediated by the kinase Btk (5, 
25). Indeed, similar to the behavior of follicular B cells in the absence of canonical NF-
B signals, ectopic expression of Bcl2 rescues the generation of follicular B cells in xid 
mice which bear a mutation in Btk, and CD23+ transitional and follicular xid B cells are 
outcompeted by wild-type B cells (26, 27). 
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MATERIALS AND METHODS 
 
Mice. Nemofl, Ikk2fl, Mb1-cre, CD21-cre and R26-Stopfl-hCD2 mice have been described 
(3, 6, 13, 28, 29). Bcl2 transgenic E-Bcl-2-22 (Bcl2Tg) mice were obtained from The 
Jackson laboratory (30). Mice were generated on or backcrossed to the C57BL/6 genetic 
background. Animal care and mouse work were conducted according to the guidelines of 
the Institutional Animal Care and Use Committee of Harvard University, the Immune 
Disease Institute (USA), the Max Delbrück Center for Molecular Medicine, the 
Landesamt für Gesundheit und Soziales (Germany) and the Bundesministerium für 
Wissenschaft und Forschung (Austria). 
For simplicity and clarity of the manuscript, the given denominations include genotypes 
as follows (+, f,  and y indicate wild type, loxP-flanked, deleted alleles and the y sex 
chromosome, respectively): Mb1-cre–: Nemof/f, Nemof/y and Nemo+/y; Nemofl Mb1-cre+: 
Nemof/f Mb1-cre+ and Nemof/y Mb1-cre+; CD21-cre–: Nemof/y or, Ikk2f/

 and Ikk2+/

; 
Nemofl CD21-cre+: Nemof/y CD21-cre+; Ikk2fl/+ CD21-cre+: Ikk2f/+ CD21-cre+ and 
Ikk2+/
 CD21-cre+; Ikk2fl CD21-cre+: Ikk2f/ CD21-cre+. Previous work (6) suggested 
that B cell development is unaffected in mice bearing either a heterozygous deletion of 
Ikk2 or loxP-flanked Ikk2 or Nemo alleles. The presence of single Ikk2-deleted alleles in 
some of our mice resulted from the occasional deletion of loxP-flanked alleles by CD21-
cre in the germ line (11). 
 
Flow cytometry. Cell suspensions from spleen and peritoneal cavity were stained with 
the following antibodies coupled to FITC, PE, PerCP, PerCP-Cy5.5, APC, PE-Cy7, 
Pacific Blue, Bv421, Bv605 or Bv785: anti-CD1d (1B1), anti-human CD2 (TS1/8), anti-
CD19 (6D5 and 1D3), anti-CD21 (7G6 and 7E9), anti-CD23 (B3B4), anti-CD38 (90), 
anti-CD93 (AA4.1), anti-CD95 (Jo2), anti-B220 (RA3-6B2) and anti-IgM (II/41 and goat 
anti-mouse Fab) purchased from affymetrix eBioscience, BD Biosciences, Biolegend and 
Jackson ImmunoResearch Laboratories. Data were recorded on FACSCalibur, 
FACSCanto II or LSRFortessa (BD Biosciences) and analyzed with FlowJo software 
(Tree Star). 
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In vitro B cell proliferation and isotype class switching. Splenic B cells were purified 
by magnetic depletion using anti-CD43 beads (Miltenyi Biotec), labeled with 10 M Cell 
Proliferation Dye eFluor® 450, 10 M Cell Proliferation Dye eFluor® 670 (affymetrix 
eBioscience) or 2.5 nM Carboxyfluorescein Diacetate Succinimidyl Ester (Molecular 
probes), and cultured in 6-well plates at 106 cells / 4 ml DMEM (Gibco) supplemented 
with 10% fetal calf serum, 2 mM L-Glutamine, 10 mM Hepes, 1 mM sodium pyruvate, 
1x non essential amino acids, 1x penicillin / streptomycin and 50 M -mercaptoethanol. 
Cells were left either untreated or stimulated with 10 g/ml F(ab’)2 fragment anti-IgM 
(Jackson ImmunoResearch Laboratories), 20 g/ml lipopolysaccharides (Sigma) and 1 or 
2 g/ml anti-CD40 (Biolegend) plus 25 or 100 ng/ml Il-4 (R&D Systems) for 4 days. 
Dead cells were stained using 1 g/ml propidium iodide (Sigma), 10 nM TO-PRO-3 
(Molecular Probes) or AnnexinV-FITC (Biolegend). Cell division of live B cells was 
subsequently determined by flow cytometry. 
 
Immunization and serum antibody titers. Mice were immunized and antibody titers 
determined as previously described (31). Briefly, animals were injected intraperitoneally 
with 100 g of (4-hydroxy-3-nitrophenyl)acetyl (NP) – chicken -globulin (NP-CGG) 
(Biosearch Technologies) in Alum (Sigma). Presence of germinal center B cells in the 
spleen was determined by flow cytometry at day 14 post-immunization. Blood was 
collected from unimmunized mice as well as 7 and 14 days after the injection of NP-
CGG to measure serum Ig titers or NP-specific IgG1 by enzyme-linked immunosorbent 
assay. 
 
Western blotting. Flow cytometry-purified B220+CD93—IgM+CD1d+hCD2+ or 
B220+CD93—IgM+CD1d+hCD2— follicular B cells were lysed using a whole cell extract 
buffer (25 mM Hepes pH 7.9, 0.3 M NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 0.5% Triton 
X100, 10 mM NaF, 10 mM Na-Pyrophosphate, 100 M Na-o-Vanadate, 2 mM DTT) 
completed with protease inhibitors (Aprotinin and PMSF). Proteins were separated by 
SDS-PAGE, and transferred on PVDF membranes (Millipore). The expression of IKK2 
and PLC2 was visualized using 10AG2 (Millipore) and Q20 (Santa Cruz Biotechnology) 
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primary antibodies, anti-mouse and anti-rabbit IgG secondary antibodies coupled to HRP 
(Jackson ImmunoResearch Laboratories), and ECL detection reagent (Amersham). 
 
5-bromo-2'-deoxyuridine labeling. Mice were given 1mg/ml of 5-bromo-2'-
deoxyuridine (Sigma) in the drinking water for 14 days. BrdU incorporation into the 
DNA of transitional and follicular B cells was determined by flow cytometry using the 
FITC BrdU Flow Kit (BD Biosciences). 
 
Statistics and graphs. The Prism software (GraphPad Software) was used to perform 
statistical analysis of the data, compute best-fitting linear function and generate graphs. 
Statistical significance of data was determined using a one-way analysis of variance 
(ANOVA) followed by a post hoc Tukey’s multiple comparisons test or a two-tailed 
unpaired Student’s t test. 
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FIGURE LEGENDS 
 
Fig. 1: Ectopic expression of Bcl2 rescues follicular B cell generation in the absence of 
NEMO. (A) Absolute cell numbers of follicular (Fo) and marginal zone (MZ) B cells in 
the spleen of Mb1-cre—, Mb1-cre+ and Nemofl Mb1-cre+ mice in (left) the absence (- 
Bcl2Tg) or (right) upon ectopic expression of Bcl2 (+ Bcl2Tg). Data are pooled from 4-15 
experiments (n = 4-19 per genotype). (B) Percent B1 cells within B cells in the peritoneal 
cavity. Data are cumulative from 5-14 experiments (n = 5-15 per group). (C) Transitional 
2 (T2) cellularity as a function of transitional 1 (T1) cell numbers. Data are pooled from 
6-15 experiments (n = 5-19 per genotype). Solid (controls) and dotted (Nemofl Mb1-cre+) 
lines represent best-fitting linear function, forced to go through the origin. (D) Percent 
CD93lo T1 and T2 cells in the spleen of Mb1-cre—, Mb1-cre+ and Nemofl Mb1-cre+ mice 
upon ectopic expression of Bcl2 (+ Bcl2Tg). Data are pooled from 9 experiments (n = 7-9 
per group). One Mb1-cre+ and 1 Nemofl Mb1-cre+ mouse were excluded from the 
analysis in A (left panel) and in B (left panel), respectively, due to aberrantly high cell 
numbers compared to the other mice of their group. Each symbol indicates one mouse 
and horizontal lines signify mean in A, B, D. *, P ≤ 0.05; **, P ≤ 0.01; ***, P ≤ 0.001. 
One-way ANOVA in A, B, D. 
 
Fig. 2: Mature B cells from Nemofl Mb1-cre+ Bcl2Tg mice are functionally defective. (A) 
Proliferation of live mature B cells from Mb1-cre— Bcl2Tg (light grey filled histogram), 
Mb1-cre+ Bcl2Tg (black histogram) and Nemofl Mb1-cre+ Bcl2Tg (black histogram) 
mice, MACS-purified, labeled with Cell Proliferation Dye eFluor® 450 and stimulated 
with 10 g/ml anti-IgM (-IgM), 20 g/ml lipopolysaccharides (LPS) or 1 g/ml anti-
CD40 + 25 ng/ml IL-4 (-CD40+IL-4) for 4 days. Dark grey filled histogram, resting 
Mb1-cre— Bcl2Tg B cells. At least 3 mice per genotype were analyzed in independent 
experiments. (B) Serum antibody isotype titers in sera of naïve mice (n = 4-7 per 
genotype). (C) Flow cytometry of CD38loCD95+ germinal center B cells within splenic 
B220+ cells of mutant and control mice 14 days after immunization with (4-hydroxy-3-
nitrophenyl)acetyl (NP) – chicken -globulin. Numbers adjacent to outlined areas specify 
percent cells in each gate. Five mice were analyzed per genotype in two experiments. (D) 
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Serum titers of NP-specific IgG1 (n = 2-6 per group). D0, unimmunized mice; D7 and 
D14, day 7 and 14 post immunization. One control mouse at day 7 did not respond to the 
immunization and was excluded from the analysis. Data are representative of two 
experiments. In B and D, symbols indicate individual mice. 
 
Fig. 3: Mild reduction of follicular B cell numbers upon deletion of NEMO or IKK2 in 
mature B cells. (A) Flow cytometry of B220+CD93+ transitional and B220+CD93— 
mature B cells within lymphocytes (top), IgM+CD23+ follicular B cells within mature B 
cells (middle), and CD1dhiCD21hi MZ B cells within CD19+ B cells (bottom) in the 
spleen of CD21-cre— and Nemofl CD21-cre+ mice. (B) Absolute cell numbers of 
follicular (Fo) and MZ B cells in CD21-cre— and Nemofl CD21-cre+ mice. Data are 
cumulative from 2 experiments (n = 3-6 per group). (C) Flow cytometry of (top) 
transitional and mature B cells among lymphocytes, and (bottom) CD1d+IgM+ follicular 
and CD1dhiIgMhi MZ B cells within mature B cells in the spleen of CD21-cre+ R26-
Stopfl-hCD2 and Ikk2fl CD21-cre+ R26-Stopfl-hCD2 mice. (D) Absolute cell numbers of 
follicular (Fo) and MZ B cells in CD21-cre—, CD21-cre+, Ikk2fl/+ CD21-cre+ and Ikk2fl 
CD21-cre+ mice. Data are pooled from 6 experiments (n = 4-6 per genotype). In A and C, 
numbers adjacent to outlined areas specify percent cells in the gate. Symbols represent 
individual mice and horizontal bars signify mean in B, D. *, P ≤ 0.05; ***, P ≤ 0.001. 
Student’s t test in B, one-way ANOVA in D. 
 
Fig. 4: IKK2-deficient follicular B cells persist but exhibit increased turnover. (A) Flow 
cytometry of human CD2 (hCD2) expression on follicular B cells in the spleen of CD21-
cre+ R26-Stopfl-hCD2, Ikk2fl/+ CD21-cre+ R26-Stopfl-hCD2 and Ikk2fl CD21-cre+ R26-
Stopfl-hCD2 mice. Numbers adjacent to outlined areas specify percent cells in each gate. 
(B) Proportions of hCD2+ follicular (Fo) B cells. Data are cumulative from 5 experiments 
(n = 3-5 per group). (C) Western blot analysis of IKK2 and PLC2 protein levels in flow 
cytometry-purified B220+CD93—CD1d+IgM+hCD2+ follicular B cells from control and 
mutant mice; follicular B cells from CD21-cre  mice were hCD2—. Western blot 
performed twice. (D) Proportions of BrdU+ (left) B220+CD19+CD93—IgM+CD23+ 
follicular and (right) B220+CD19+CD93+ transitional B cells in mice given BrdU in 
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drinking water for 14 days, as determined by flow cytometry. Data are cumulative from 2 
experiments (n = 5-6 per group). One Ikk2fl CD21-cre+ mouse was excluded from the 
analysis due to sickness in D. In B and D, symbols represent individual mice and 
horizontal bars signify mean. **, P ≤ 0.01; ***, P ≤ 0.001. One-way ANOVA in B and D. 
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SUPPLEMENTARY FIGURE LEGENDS 
 
Fig. S1: Identification of mature follicular and marginal zone B cells. Flow cytometry of 
(Top) B220+CD93+ transitional and B220+CD93— mature B cells within splenic 
B220+CD19+ B cells, as well as (Bottom) IgM+CD1d+ follicular and IgMhiCD1dhi MZ B 
within splenic mature B cells of Mb1-cre—, Mb1-cre+ and Nemofl Mb1-cre+ mice in the 
absence (n = 4-5 per genotype in 4 experiments) (A) or upon ectopic expression of Bcl2 
(n = 14-19 per genotype in 15 experiments) (B; Bcl2Tg). Numbers adjacent to outlined 
areas specify percent cells in each gate. 
 
Fig. S2: Evaluation of B1 cell proportions. Flow cytometry of B220lo/—CD19+ B1 and 
B220+CD19+ B2 cells gated on CD19+ B cells in the peritoneal cavity of Mb1-cre—, Mb1-
cre+ and Nemofl Mb1-cre+ mice in the absence (n = 5-6 per genotype in 5 experiments) 
(A) or upon ectopic expression of Bcl2 (n = 12-15 per genotype in 14 experiments) (B; 
Bcl2Tg). Numbers adjacent to outlined areas indicate percent cells in the gate. 
  
Fig. S3: Detection of Transitional 1 and 2 B cells. Flow cytometry of IgMhiCD23— 
transitional 1 and IgMhiCD23+ transitional 2 subsets within B220+CD19+CD93+ 
transitional B cells in the spleen of Mb1-cre—, Mb1-cre+ and Nemofl Mb1-cre+ mice in 
the absence (n = 5-7 per genotype in 6 experiments) (A) or upon ectopic expression of 
Bcl2 (n = 14-19 per genotype in 15 experiments) (B; Bcl2Tg). Numbers adjacent to 
outlined areas specify percent cells in the gate. 
 
Fig. S4: Determination of the percentage of CD93lo cells within transitional 1 and 2 
populations. Proportions of CD93loB220+ cells within splenic 
B220+CD19+CD93+IgMhiCD23— transitional 1 and B220+CD19+CD93+IgMhiCD23+ 
transitional 2 B cells measured by flow cytometry in Mb1-cre— Bcl2Tg, Mb1-cre+ Bcl2Tg 
and Nemofl Mb1-cre+ Bcl2Tg mice (n = 7-9 per genotype in 9 experiments). Numbers 
adjacent to outlined areas specify percent cells in the gate. Transitional 2 cells from 
control mice were used as the reference to set the CD93lo gate. 
 
 2 
Fig. S5: Proportions of hCD2+ cells within the B1a and B2 cell subsets. Percent hCD2+ 
B220+CD19+ B2 and B220lo/—CD19+CD5+CD43+ B1a cells in the peritoneal cavity of 
CD21-cre+ R26-Stopfl-hCD2 mice determined by flow cytometry. Data are pooled from 3 
experiments (n = 3). Each symbol indicates one mouse and horizontal lines signify mean. 
***, P ≤ 0.001. Student’s t test. 
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